Literature DB >> 159975

Reticuloendothelial and mesangial function in murine immune complex glomerulonephritis.

P E Hoffsten, A Swerdlin, M Bartell, C L Hill, J Venverloh, K Brotherson, S Klahr.   

Abstract

The function of the mesangial and reticuloendothelial system was evaluated in normal mice and in mice with nephritis induced by lymphocytic choriomeningitis (LCM) virus infection. Heat-aggregated human immunoglobulin (AlgG) and colloidal carbon served as traceable materials which could be detected in animals' blood and tissues. LCM virus-infected proteinuric (LCM-P) mice, as compared to normal mice or LCM-infected nonproteinuric (LCM) mice, had greater accumulation of AIgG in their glomeruli at all times of examination following i.p. injection of AIgG. The removal rate of AIgG from the kidney, however, was the same in normal and LCM-P mice, indicating an unimpaired mesangial clearing system. This suggested that other mechanisms were responsible for the increased glomerular accumulation of AIgG in LCM-P mice. Reticuloendothelial function was examined directly by i.v. injection of AIgG or colloidal carbon. The data demonstrate that in this model of immune complex glomerulonephritis, colloidal material tested was removed from the blood at a slower rate than it was in normal mice. Deficient clearance of endogenous blood-borne immune complex-like material may be one of the factors playing a role in the accumulation of immune complex-like material in the glomeruli of these nephritic animals.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159975     DOI: 10.1038/ki.1979.20

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  Antigenic charge as a factor in resistance to immunosuppressive therapy.

Authors:  S G Adler; H Y Wang; A H Cohen; W A Border
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

Review 2.  Glomerular response to immunologic injury, studies on progression.

Authors:  P D Killen; C Melcion; J F Bonadio; L Morel-Maroger; G E Striker
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Charge-related deposition of immune complexes in the glomerular basement membrane is independent of Fc effector function.

Authors:  T Caulin-Glaser; S N Emancipator; G R Gallo; M E Lamm
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

4.  The mesangium and glomerulonephritis.

Authors:  R B Sterzel; D H Lovett; H D Stein; M Kashgarian
Journal:  Klin Wochenschr       Date:  1982-09-15

5.  Glomerular subendothelial and subepithelial immune complexes, containing the same antigen, are removed at different rates.

Authors:  M Mannik; S A Stapleton; M W Burns; C E Alpers; V J Gauthier
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

6.  Macromolecular charge and reticuloendothelial function: comparison between the kinetics of administered native and cationized ferritins and the corresponding immune complexes in the mouse.

Authors:  C Genin; F Cosio; A F Michael
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

7.  Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit.

Authors:  S G Adler; H Wang; H J Ward; A H Cohen; W A Border
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

8.  Progressive cytomegalovirus glomerulonephritis - An experimental model.

Authors:  R W Wehner; R G Smith
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

9.  The effect of protein deficiency on the development of chronic antigen-antibody complex disease in mice.

Authors:  M C Reinhardt; M Devey; M Collins; B Gregory; M W Steward
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

10.  Mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Identification of resident macrophages in renal medullary and cortical interstitium and the juxtaglomerular complex.

Authors:  D A Hume; S Gordon
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.